» Articles » PMID: 35857796

Predictors of Loss to Follow Up from Antiretroviral Therapy Among Adolescents with HIV/AIDS in Tanzania

Overview
Journal PLoS One
Date 2022 Jul 20
PMID 35857796
Authors
Affiliations
Soon will be listed here.
Abstract

Access to Antiretroviral Therapy (ART) is threatened by the increased rate of loss to follow-up (LTFU) among adolescents on ART care. We investigated the rate of LTFU from HIV care and associated predictors among adolescents living with HIV/AIDS in Tanzania. A retrospective cohort analysis of adolescents on ART from January 2014 to December 2016 was performed. Kaplan-Meier method was used to determine failure probabilities and the Cox proportion hazard regression model was used to determine predictors of loss to follow up. A total of 25,484 adolescents were on ART between 2014 and 2016, of whom 78.4% were female and 42% of adolescents were lost to follow-up. Predictors associated with LTFU included; adolescents aged 15-19 years (adjusted hazard ratio (aHR): 1.57; 95% Confidence Interval (CI); 1.47-1.69), having HIV/TB co-infection (aHR: 1.58; 95% CI, 1.32-1.89), attending care at dispensaries (aHR: 1.12; 95% CI, 1.07-1.18) or health center (aHR: 1.10; 95% CI, 1.04-1.15), and being malnourished (aHR: 2.27; 95% CI,1.56-3.23). Moreover, residing in the Lake Zone and having advanced HIV disease were associated with LTFU. These findings highlight the high rate of LTFU and the need for intervention targeting older adolescents with advanced diseases and strengthening primary public facilities to achieve the 2030 goal of ending HIV as a public health threat.

Citing Articles

Estimating the costs of adolescent HIV care visits and an intervention to facilitate transition to adult care in Kenya.

Saldarriaga E, Beima-Sofie K, Wamalwa D, Mugo C, Njuguna I, Onyango A PLoS One. 2024; 19(2):e0296734.

PMID: 38330069 PMC: 10852328. DOI: 10.1371/journal.pone.0296734.


Loss to Follow-up and Death Among Individuals With Newly Diagnosed Human Immunodeficiency Virus Receiving Dolutegravir-Based First-Line Antiretroviral Treatment in Eastern Ethiopia: Implications for 95% United Nations Targets.

Gemechu A, Mihret A, Aseffa A, Howe R, Seyoum B, Mulu A Open Forum Infect Dis. 2023; 10(11):ofad522.

PMID: 37953815 PMC: 10638489. DOI: 10.1093/ofid/ofad522.


Risk factors for interruption in treatment among HIV-infected adolescence attending health care and treatment clinics in Tanzania.

Mtisi E, Mushy S, Mkawe S, Ndjovu A, Mboggo E, Mlay B AIDS Res Ther. 2023; 20(1):19.

PMID: 36998051 PMC: 10064772. DOI: 10.1186/s12981-023-00512-4.

References
1.
Jerene D, Abebe W, Taye K, Ruff A, Hallstrom I . Adolescents living with HIV are at higher risk of death and loss to follow up from care: Analysis of cohort data from eight health facilities in Ethiopia. PLoS One. 2019; 14(10):e0223655. PMC: 6797201. DOI: 10.1371/journal.pone.0223655. View

2.
Nwe T, Lee S, Li L, Hsan M, Htwe A, Oo H . Antiretroviral therapy (ART) coverage at public and private ART facilities in Myanmar. AIDS Care. 2020; 33(9):1218-1227. PMC: 7759597. DOI: 10.1080/09540121.2020.1781758. View

3.
Fish R, Judd A, Jungmann E, OLeary C, Foster C . Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med. 2013; 15(4):239-44. DOI: 10.1111/hiv.12091. View

4.
Evans D, Menezes C, Mahomed K, Macdonald P, Untiedt S, Levin L . Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses. 2013; 29(6):892-900. PMC: 3653371. DOI: 10.1089/AID.2012.0215. View

5.
Kiwanuka J, Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N . Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda. PLoS One. 2020; 15(4):e0217606. PMC: 7138304. DOI: 10.1371/journal.pone.0217606. View